跳到正文
原文
Endpoints News 生物医药· Max Bayer·· 3 天前AI 评分45

Helus Pharma III 期抑郁症试验取得积极结果

Helus Pharma notches successful Phase 3 depression readout

AI 导读

Helus Pharma 的主打药物在 III 期试验中显示比安慰剂更能改善抑郁症状,但投资者反应略显谨慎。

正文

Helus Phar­ma, part of the bud­ding class of psy­che­delics com­pa­nies, said its lead drug im­proved de­pres­sion symp­toms com­pared to place­bo, but in­vestors ap­peared slight­ly skit­tish …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news